TANG KEVIN C

Average Profitability
212.08%
Insider Buys Quantity
36
Insider Buys Sum
$183.03M
Insider Sells Quantity
13
Insider Sells Sum
$232.53M

Insider Activity of TANG KEVIN C

According to the SEC Form 4 filings, TANG KEVIN C, being in a position of

  1. director at Aurinia Pharmaceuticals Inc.,
    оver the last 12 months, has bought 1200000 shares for $10.82M, and sold 0 shares,
    over all time since 2024-12-05, has bought 1200000 shares for $10.82M, and sold 0 shares.

The largest purchase of all time was on 2017-01-19 and amounted to 4918032 shares of Heron Therapeutics, Inc. for $60M.

The largest sale of all time was on 2018-09-12 and amounted to 5390000 shares of Heron Therapeutics, Inc. for $192.69M.

Biography of TANG KEVIN C

No biography is available at this moment.

2024-12-09PurchaseAurinia Pharmaceuticals Inc.
AUPH
director
500,000
0.346%
$9.09$4.54M+5.04%
2024-12-06PurchaseAurinia Pharmaceuticals Inc.
AUPH
director
400,000
0.2812%
$9.01$3.6M+6.94%
2024-12-05PurchaseAurinia Pharmaceuticals Inc.
AUPH
director
300,000
0.2089%
$8.91$2.67M+6.53%
2024-09-18PurchaseSingular Genomics Systems, Inc.
OMIC
10 percent owner
32,000
1.3143%
$17.21$550,720+16.44%
2024-09-17PurchaseSingular Genomics Systems, Inc.
OMIC
10 percent owner
40,000
1.5204%
$15.33$613,200+20.51%
2024-09-16PurchaseSingular Genomics Systems, Inc.
OMIC
10 percent owner
50,416
2.0091%
$12.74$642,300+51.44%
2021-11-23SaleAptevo Therapeutics Inc.
APVO
921,336
12.987%
$11.25$10.37M-73.69%
2021-11-22SaleAptevo Therapeutics Inc.
APVO
10 percent owner
255,331
5.9122%
$7.03$1.8M-30.86%
2021-11-19SaleAptevo Therapeutics Inc.
APVO
10 percent owner
213,800
4.7422%
$7.59$1.62M-38.63%
2021-11-18SaleAptevo Therapeutics Inc.
APVO
10 percent owner
369,533
8.1153%
$8.34$3.08M-44.69%
2020-11-06PurchaseAptevo Therapeutics Inc.
APVO
10 percent owner
348,554
7.5668%
$22.73$7.92M+8.23%
2020-11-05PurchaseAptevo Therapeutics Inc.
APVO
10 percent owner
1.25M
25.0765%
$18.78$23.5M+20.82%
2020-11-04PurchaseAptevo Therapeutics Inc.
APVO
10 percent owner
1.27M
24.3464%
$14.34$18.27M+50.91%
2019-10-04PurchaseHeron Therapeutics, Inc.
HRTX
director
571,428
0.3221%
$8.75$5M+2.41%
2018-09-12SaleHeron Therapeutics, Inc.
HRTX
5.39M
7.0856%
$35.75$192.69M-29.59%
2018-03-29PurchaseHeron Therapeutics, Inc.
HRTX
384,616
0.5598%
$26.00$10M+8.51%
2017-02-23PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
10 percent owner
134,200
3.3648%
$4.34$582,079-53.33%
2017-01-19PurchaseHeron Therapeutics, Inc.
HRTX
4.92M
8.5734%
$12.20$60M+10.47%
2015-06-10PurchaseHeron Therapeutics, Inc.
HRTX
242,424
0.6699%
$24.75$6M-11.71%
2015-06-02PurchaseHeron Therapeutics, Inc.
HRTX
64,790
0.2146%
$23.84$1.54M+12.42%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.